Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02400502 · ClinicalTrials.gov registry record · NA
Integrated Coping and Awareness Training
A NA study of Schizophrenia, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02400502: Completed NA study of Schizophrenia, sponsored by University of North Carolina, Chapel Hill.
NCT02400502 is a NA study of Schizophrenia that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 6 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02400502, a NA study of Schizophrenia, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Integrated Coping and Awareness Therapy is a novel therapeutic intervention combining strategies to improve stress reactivity and increase meaningful coping, as well as a range of possible proximal (e.g. immune indices of stress reactivity, symptom severity) and distal measures (e.g. relapse, quality of life).
Primary Outcome
Salivary cortisol measured before, during and after a social stressor test.
Conditions Studied
Interventions
- BEHAVIORAL I-CAT Therapy
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT02400502 record still lists
NCT02400502 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which I-CAT Therapy is the first listed.
NCT02400502 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02400502 about?
NCT02400502 is a clinical study titled "Integrated Coping and Awareness Training". Integrated Coping and Awareness Therapy is a novel therapeutic intervention combining strategies to improve stress reactivity and increase meaningful coping, as well as a range of possible proximal (e.g. immune indices of stress reactivity, symptom severity) and distal measures (e.g. relapse, qualit...
What is the current status of trial NCT02400502?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2015-03. Estimated completion is 2016-04.
What conditions does trial NCT02400502 study?
This clinical trial studies the following conditions: Schizophrenia.
What interventions are being tested in trial NCT02400502?
The interventions under investigation include: I-CAT Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02400502?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02400502 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02400502's enrollment target sits among peer trials
6 316th of 315 the lowest of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia